Delivery Order SPE2DB22D1106-SPE2DB24FEKG3
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The order has a potential value of $16,788.00 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that regularly provides pharmaceuticals and medical supplies to support U.S. government agencies,...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,315.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML. This delivery order has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. Amerisourcebergen Drug Corp also holds a $999,999,999.00 indefinite delivery contract with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,578 firm fixed-price delivery order contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the provision of the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract is a firm fixed price delivery order with a ceiling value of $1,578.00 and a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA...
- This federal contract award is a firm fixed price delivery order valued at $1,208.32, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of February 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of February 21, 2024 and a potential value of $7,935.51. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of up to...
- This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, with Amerisourcebergen Drug Corp, a pharmaceutical distribution and medical supply company, for the procurement of MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The award has a ceiling value of $3,156.00 and is structured as a firm fixed price contract with a period of performance through March 11, 2024. Amerisourcebergen Drug Corp is the prime...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $10,170.76 award has a completion date of March 7, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to provide the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The $1,315.00 firm fixed price delivery order has a performance period through March 11, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) the company...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $2,400.00 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor and has an active indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEKG3Delivery Order
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a firm fixed price, a ceiling value of $1,315.00, and an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order was not set aside for any specific business type.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/8/24 |